Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways
about
Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chainThe role of saliva in tick feedingHuman plasma kallikrein. A rapid purification method with high yieldA monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritisMechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factorSafety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study.Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikreinRole of the light chain of high molecular weight kininogen in adhesion, cell-associated proteolysis and angiogenesis.The kallikrein-kinin system in humans.Human neutrophils contain and bind high molecular weight kininogen.Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.Antiphospholipid antibodies and kininogens in pathologic pregnancies: a review.Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasmaRole of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension.High-molecular weight kininogen. A secreted platelet proteinKallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.A brief historical review of the waterfall/cascade of blood coagulation.High molecular weight kininogen binds to unstimulated plateletsFlaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.Activation of the kallikrein-kinin system and release of new kinins through alternative cleavage of kininogens by microbial and human cell proteinases.Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency.High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and plateletsCharacterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen.Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.Turnover of human and monkey plasma kininogens in rhesus monkeys.Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.Purification of high molecular weight kininogen and the role of this agent in blood coagulation.Association of factor XI and high molecular weight kininogen in human plasma.Plasma kallikrein activation and inhibition during typhoid fever.Mechanism of the participation of the contact system in the Vroman effect. Review and summary.Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate.Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogensA Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development ConceptCongenital prekallikrein deficiency.
P2860
Q24564856-0DFA2955-1345-4744-A6A3-059F10ED956AQ27490448-63F81AB8-16D0-44CF-9687-A65CA61A2B30Q28367604-C7892C44-CB36-46F0-8D0F-262C187511B7Q28572406-6025E606-975A-4E7C-A796-DF3116EC6F73Q28628750-B5BF7D5D-5213-4F8E-B1DD-88350EBB8496Q33167153-36208574-A445-4FC0-868F-5F57A64F789AQ33928318-63405AA6-DD65-483B-B44A-F3A164E9A3A9Q33982766-9FADC3A9-A00D-45CA-8658-CE3E958347E9Q34189968-56F8BDAA-FD19-427F-9C4C-219025A91D94Q34570447-3F53B826-1680-44CF-8324-94797FD99481Q34576164-9EFF385D-4658-4497-BF77-27BE3DB6AE8FQ34607071-5565126C-724E-430D-8EEA-3E0E0F99D216Q34767031-513DFE31-08E2-4853-95E1-C5A41B2AD9B1Q35037706-C302E84B-ADAA-47DA-A33A-844AEF55AD12Q35058622-7B1AED4D-17E7-49D5-BEC5-2B626A55F2B4Q35081897-1357A17A-3F95-4B4E-8A46-F7CA49D624ABQ35207304-5DC94A1C-0BE9-4495-81C8-C22294D8F823Q35352171-332B47B6-1177-4E1E-BD80-C26B89117F6EQ35564946-435B60BF-441C-40FF-A9EE-D63D34468B4DQ35808722-986CA989-4E3A-4E26-8631-2F7ADFE5FD79Q35905313-AF974D98-AC30-45B8-B757-5FA3EB756DDEQ35970392-9111CDC4-4F99-46EA-8EFF-EFD09880C994Q36144212-403FA921-F658-4F0D-89F1-78786A29A5D7Q36220256-9E31C365-F5CB-4F0A-A8BB-39148B13D063Q36340730-E7ECB9E1-F330-45B9-9501-2E918A5EAE21Q37020391-59BB19EC-4DAA-4778-9424-E8AF94057E4DQ37034738-D0C283DE-D02A-42AF-B4DC-A22BFD778B49Q37045271-E04B49B4-F0B6-4E2B-B1C1-063857944761Q37045297-C23CD394-A7F2-48A1-830C-CF262588323EQ37046520-CF2791DF-4C3E-4F2C-8D25-6B559E52D4C1Q37046547-5CF7C10D-EB09-4F7C-94D1-29B821EA5D17Q37049066-F06CAE27-58FA-4449-BB2E-9CBFEC8CFE4EQ37050492-A6BAA463-BB0E-42ED-BF83-D13F0E408656Q37188939-C15BF8B9-8AB2-42D3-B4AC-7EFA5504E5CEQ37312644-18F579BD-A179-4145-A775-AEE8EF9238CFQ37316920-8DED71CA-B3DA-418A-8EB7-892878155944Q37584724-D03C2B3E-6ADC-4A00-90C7-47EDB70600B4Q37616021-43CECA05-1507-4A00-85E5-84099B22AD13Q37709440-06C9BDDC-751A-4CB9-8712-74AB8FDA829EQ37810965-12DDB220-FA6A-43A4-B73F-40B65026CF14
P2860
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways
description
1975 nî lūn-bûn
@nan
1975 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Williams trait. Human kininoge ...... eman factor-dependent pathways
@ast
Williams trait. Human kininoge ...... eman factor-dependent pathways
@en
Williams trait. Human kininoge ...... eman factor-dependent pathways
@nl
type
label
Williams trait. Human kininoge ...... eman factor-dependent pathways
@ast
Williams trait. Human kininoge ...... eman factor-dependent pathways
@en
Williams trait. Human kininoge ...... eman factor-dependent pathways
@nl
prefLabel
Williams trait. Human kininoge ...... eman factor-dependent pathways
@ast
Williams trait. Human kininoge ...... eman factor-dependent pathways
@en
Williams trait. Human kininoge ...... eman factor-dependent pathways
@nl
P2093
P2860
P356
P1476
Williams trait. Human kininoge ...... eman factor-dependent pathways
@en
P2093
A Bagdasarian
A P Kaplan
J A Guimaraes
J V Pierce
R C Talamo
R W Colman
P2860
P304
P356
10.1172/JCI108247
P407
P577
1975-12-01T00:00:00Z